![James G. Barsoum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
James G.
Barsoum worked as the Director of Molecular & Cellular Biology at Biogen MA, Inc. from 1987 to 2003.
He then worked as the Senior Vice President of Research at Synta Pharmaceuticals Corp.
from 2003 to 2009.
After that, he served as the Chief Scientific Officer at Translate Bio, Inc. and Theracrine, Inc. respectively.
Barsoum earned a doctorate degree from the Massachusetts Institute of Technology.
Antiguos cargos conocidos de James G. Barsoum.
| Empresas | Cargo | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Director Técnico/Científico/I+D | 12/09/2016 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Director Técnico/Científico/I+D | 30/10/2009 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Corporate Officer/Principal | 01/02/2003 |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Director Técnico/Científico/I+D | - |
Formación de James G. Barsoum.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
52
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Theracrine, Inc.
Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- James G. Barsoum
